Literature DB >> 238697

The selectivity of beta-adrenoceptor antagonists on cardiovascular and bronchodilator responses to isoprenaline in the anaesthetized dog.

M J Daly, J J Flook, G P Levy.   

Abstract

1 The actions of five beta-adrenoceptor antagonists, chosen because of reported differences in their selectivities, were compared using the positive chronotropic, vasodepressor and bronchodilator responses to isoprenaline in anesthetized dogs. 2 Propranolol was a potent antagonist of the isoprenaline responses in all three systems. 3 Practolol and acebutolol (M & B 17,803) blocked the positive chronotropic responses to isoprenaline to a greater extent than the vasodepressor or bronchodilator responses. 4 Butoxamine and alpha-methyl dichloroisoprenaline showed the opposite selectivity, blocking the vasodepressor and bronchodilator responses to isoprenaline to a greater extent than positive chronotropic responses. However, both drugs were considerably less potent than the other antagonists studied and their selectivities were less clear-cut than those of practolol or acebutolol. 5 All the antagonists lowered the resting heart rate and to a lesser extent the diastolic blood pressure. The effects of propranolol, practolol and acebutolol on heart rate probably result from cardiac beta-adrenoceptor blockade. With butoxamine and alpha-methyl dichloro isoprenaline, however, the effects on heart rate probably result from a direct cardiodepressant action. 6 The relevance of the results to the problem of the sub-classification of beta-adrenoceptors is discussed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 238697      PMCID: PMC1666304          DOI: 10.1111/j.1476-5381.1975.tb07347.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  33 in total

1.  EFFECT OF A BETA-ADRENERGIC-BLOCKING AGENT, PROPRANOLOL, ON ASTHMATICS.

Authors:  R S MCNEILL
Journal:  Lancet       Date:  1964-11-21       Impact factor: 79.321

2.  Cardio-selective beta-blockade.

Authors:  A M Barrett; A F Crowther; D Dunlop; R G Shanks; L H Smith
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1968

3.  Pharmacology of M & B 17803A in man and dog.

Authors:  R H Briant; C T Dollery; T Fenyvesi; C F George
Journal:  Br J Pharmacol       Date:  1971-10       Impact factor: 8.739

4.  Experimental bronchopneumopathy due to SO2 in the dog.

Authors:  J Lulling; J Prignot; P Lievens
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1968

5.  The beta-blocking effect of practolol in asthmatics.

Authors:  C Bernecker; I Roetscher
Journal:  Lancet       Date:  1970-09-26       Impact factor: 79.321

6.  The effect of "selective" beta-adrenoceptor blocking drugs on the myocardial circulation.

Authors:  J R Parratt; R M Wadsworth
Journal:  Br J Pharmacol       Date:  1970-06       Impact factor: 8.739

7.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

8.  Blockade of biochemical and physiological responses of cardiac muscle to norepinephrine by N-tert.-butylmethoxamine (butoxamine).

Authors:  W B Wastila; J Y Su; W F Friedman; S E Mayer
Journal:  J Pharmacol Exp Ther       Date:  1972-04       Impact factor: 4.030

9.  The detection of differential beta-adrenoceptor blockade in the cat.

Authors:  M W Parkes
Journal:  Br J Pharmacol       Date:  1973-08       Impact factor: 8.739

10.  Effects of beta-adrenergic receptor blockade on airway conductance and lung volume in normal and asthmatic subjects.

Authors:  P S Richardson; G M Sterling
Journal:  Br Med J       Date:  1969-07-19
View more
  12 in total

1.  Classification of the beta-adrenoceptors that mediate inhibition of pentagastrin-induced gastric acid secretion in the dog [proceedings].

Authors:  M J Daly; J M Long; R Stables
Journal:  Br J Pharmacol       Date:  1977-11       Impact factor: 8.739

2.  Exercise responses of healthy subjects in the evaluation of cardioselectivity of beta-blockers.

Authors:  K L Woods; S P Linton; M J Kendall; E B Faragher; R J Grieve
Journal:  Eur J Clin Pharmacol       Date:  1979-05-21       Impact factor: 2.953

3.  The role of beta1- and beta2-adrenoceptors in the inhibition of gastric acid secretion in the dog.

Authors:  M J Daly; J M Long; R Stables
Journal:  Br J Pharmacol       Date:  1978-09       Impact factor: 8.739

4.  Selectivity of beta-adrenoceptor agonists and antagonists on bronchial, skeletal, vascular and cardiac muscle in the anaesthetized cat.

Authors:  G H Apperley; M J Daly; G P Levy
Journal:  Br J Pharmacol       Date:  1976-06       Impact factor: 8.739

5.  The effect of carazolol on the cardiovascular responses to adrenaline in stress sensitive pigs.

Authors:  N G Gregory; L J Wilkins
Journal:  Vet Res Commun       Date:  1982-05       Impact factor: 2.459

Review 6.  Acebutolol. A review of its pharmacological properties and therapeutic efficacy in hypertension, angina pectoris and arrhythmia.

Authors:  B N Singh; W R Thoden; A Ward
Journal:  Drugs       Date:  1985-06       Impact factor: 9.546

7.  Comparative effects of acebutolol and practolol on the lipolytic response to isoprenaline.

Authors:  D O Gibbons; A F Lant; A Ashford; R F Collins; S Pinder
Journal:  Br J Clin Pharmacol       Date:  1976-02       Impact factor: 4.335

8.  Inhibition by salmeterol of increased vascular permeability and granulocyte accumulation in guinea-pig lung and skin.

Authors:  C J Whelan; M Johnson
Journal:  Br J Pharmacol       Date:  1992-04       Impact factor: 8.739

9.  The effect of (-)-isoprenaline and (+/-)-salbutamol on pepsinogen and acid secretion in the dog.

Authors:  M J Daly; R Stables
Journal:  Br J Pharmacol       Date:  1977-02       Impact factor: 8.739

10.  The selectivity of beta-adrenoceptor antagonists on isoprenaline-induced changes in heart rate, blood pressure, soleus muscle contractility and airways function in anaesthetized cats.

Authors:  L G Letts; D P Richardson; D M Temple; L R Williams
Journal:  Br J Pharmacol       Date:  1983-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.